The drug Vyvanse, which is being aggressively marketed as a treatment for binge eating, is classified by the federal government as having a high potential for abuse, The New York Times reports.
The drug is a type of amphetamine. Retired tennis player Monica Seles, a paid spokeswoman for the company that makes Vyvanse, has been on a media tour to promote the drug. Shire, which makes Vyvanse, received approval late last month to market the drug for binge-eating disorder.
Vyvanse was already approved to treat attention deficit hyperactivity disorder (ADHD). Federal officials have cited the company for inappropriately marketing Vyvanse and other ADHD drugs.